Edesa Biotech Inc EDSA:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/29/22 EDT
1.42quote price arrow up+0.03 (+2.16%)
Volume
14,426
52 week range
1.30 - 8.95
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.42
  • 52 Week High8.95
  • 52 Week High Date11/03/21
  • 52 Week Low1.30
  • 52 Week Low Date06/30/22

Key Stats

  • Market Cap21.95M
  • Shares Out15.46M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change-74.78

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.42
  • 52 Week High8.95
  • 52 Week High Date11/03/21
  • 52 Week Low1.30
  • 52 Week Low Date06/30/22
  • Market Cap21.95M
  • Shares Out15.46M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change-74.78

RATIOS/PROFITABILITY

  • EPS (TTM)-1.31
  • P/E (TTM)-1.08
  • Fwd P/E (NTM)-3.59
  • EBITDA (TTM)-20.901M
  • ROE (TTM)-133.29%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-362.00%
  • Net Margin (TTM)-2,334,322.00%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date12/17/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Edesa Biotech Inc

 

Content From Our Affiliates

Profile

MORE
Edesa Biotech, Inc. is a Canada-based biopharmaceutical company. The Company is focused on acquiring, developing and commercializing clinical stage drugs for inflammatory and immune related diseases with clear unmet medical needs. It is organized under the laws of British Columbia, Canada. The Company’s two lead product candidates, EB05 and EB01, are in later stage clinical studies. EB05 is a monoclonal antibody therapy, which the Company is developing as a treatment for...
Sean Macdonald
Independent Chairman of the Board
Pardeep Nijhawan M.D.
Chief Executive Officer, Corporate Secretary and Director
Michael Brooks Ph.D.
President
Kathi Niffenegger CPA
Chief Financial Officer
Address
100 Spy Crt
Markham, ON
L3R 5H6
Canada

Top Peers

SYMBOLLASTCHG%CHG
AEZS
Aeterna Zentaris Inc
3.83-0.09-2.30%
LMNL
Liminal BioSciences Inc
0.42-0.0343-7.5499%
DMAC
DiaMedica Therapeutics Inc
1.24-0.04-3.12%
SBM
CWBR
CohBar Inc
2.97-0.06-1.98%